Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Perinatal Medicine|November 2, 2025
Management and outcomes of periviable infants in Slovenia: a decade of experiencePolona Rajar, Tamara Čopi, Mateja Sladič, et al.Plos One|January 1, 2020
Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet model of asphyxiaPolona Rajar, Monica Åsegg-Atneosen, Ola Didrik Saugstad, et al.Journal of Applied Genetics|March 23, 2018
Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotypingLuca Lovrečić, Polona Rajar, Marija Volk, et al.Molecular Biology Reports|December 13, 2022
Assessing nuclear versus mitochondrial cell-free DNA (cfDNA) by qRT-PCR and droplet digital PCR using a piglet model of perinatal asphyxiaMarie Bitenc, Benedicte Grebstad Tune, Maria Melheim, et al.Alimentary Pharmacology & Therapeutics|February 21, 2019
Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel diseaseDavid Drobne, Tina Kurent, Saša Golob, et al.Nature Communications|July 17, 2024
Prolonged hospitalization signature and early antibiotic effects on the nasopharyngeal resistome in preterm infantsAchal Dhariwal, Polona Rajar, Gabriela Salvadori, et al.Neonatology|December 3, 2020
Antibiotic Stewardship in Premature Infants: A Systematic ReviewPolona Rajar, Ola D Saugstad, Dag Berild, et al.Frontiers in Microbiology|January 9, 2023
Microbial DNA extraction of high-host content and low biomass samples: Optimized protocol for nasopharynx metagenomic studiesPolona Rajar, Achal Dhariwal, Gabriela Salvadori, et al.Scandinavian Journal of Gastroenterology|July 11, 2018
Success and safety of high infliximab trough levels in inflammatory bowel diseaseDavid Drobne, Tina Kurent, Sasa Golob, et al.Pageof 1